news
Press release
 
August 5, 2019
Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

WALTHAM, MA August 5, 2019 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will present at the Canaccord Genuity 39th Annual Growth Conference as follows:

Date: Thursday, August 8, 2019
Time: 3:30 p.m. EDT
Location: InterContinental Boston, Boston
Webcast: http://wsw.com/webcast/canaccord35/cvrs

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at investors.corindus.com, under the News & Events Section

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world. For additional information, visit www.corindus.com, and follow @CorindusInc.

Investor Contact:

Lisa Wilson
In-Site Communications, Inc.
T: 917-543-9932
ir@corindus.com
 
close the window

Please complete the form below in order to download the content.







close the window

Please complete the form below in order to download the content.







close the window

Please fill out this brief form to subscribe to our email newsletter.





close the window

Please complete the form below and a member of our Clinical team will contact you.






close the window

Please complete the form below in order to download the content.







close the window